BioPhama Corvus Stock Doubles with Trial of Cancer Immunotherapy CPI-006 on Covid-19 Patients

Corvus Pharmaceuticals shares shot up 115% after news that it has started Phase 1 Trial of CPI-006
$CRVS $NVAX $VXRT $BVXV #treatment #covid #stocks #investors https://t.co/y5WCbGZ0QA